The Clorox Company (CLX) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges
3 Reasons to Sell CLX and 1 Stock to Buy Instead
Clorox CEO Search Puts Leadership And Recovery Efforts Under The Spotlight
The Clorox Company: Investors Are Not Happy, More Pain Ahead
Clorox Board of Directors to Initiate Comprehensive CEO Search Process
Clorox CEO Linda Rendle To Step Down For Health Reasons As Board Launches Search For New CEO
Clorox (CLX) Valuation Check As Investigation And Margin Outlook Reset Shake Investor Confidence
Pomerantz Probe Adds Governance And Legal Risk To Clorox Recovery Story
Wells Fargo Maintains Equal-Weight on Clorox, Lowers Price Target to $95
Q1 Earnings Outperformers: Clorox (NYSE:CLX) And The Rest Of The Household Products Stocks
How Investors Are Reacting To Clorox (CLX) Bond Issuance And Lowered Earnings Guidance
Is Wall Street Bullish or Bearish on Clorox Company Stock?
Clorox to Present at dbAccess Global Consumer Conference
Jensen Quality Mid Cap Fund Trimmed The Clorox Company (CLX) to Improve Risk-Return Profile
Clorox Investigation Puts GOJO Deal Margins And Dividend Path In Focus
A Look At Clorox’s Valuation After Weak Q3 Results And A Lowered Full Year Outlook
Morgan Stanley Sees Rising Cost Pressures for Clorox (CLX)
If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff
Contrarian Take: This High-Yield Dividend Stock Is a Buy in May Despite Falling to an 11-Year Low
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.